Kiadis Pharma is a biopharmaceutical company based in Amsterdam, The Netherlands. We focus on the treatment of blood cancers and inherited blood disorders aiming to make bone marrow transplantations, a procedure that is often the last hope for patients, safer and more efficient. We are currently building our warehouse and manufacturing plant in Amsterdam, and need a passionate and driven Warehouse and Materials Manager to help build our process and team.
In this role you will be responsible for developing and implementing the structure and framework for all warehousing activities at the Amsterdam production facility. As the warehouse activities have to be built from scratch, a combination of conceptual skills and hands on mentality is required. This is a challenging and cross-functional role interacting with Clinical Operations, Manufacturing, Quality affairs and Quality Control and Logistical Service Providers.
Can you take on the challenge to develop an infrastructure and implement a fully operational GMP warehouse facility?
Your Responsibilities will include:
The ideal candidate would have:
A challenging position in an innovative, fast growing, biotechnology company. Working in a fast-paced dynamic environment brings the opportunity to make your own mark within the organization.
You will be rewarded a competitive remuneration package, the opportunity for personal development and to contribute in making a huge difference for patients.
For further information, please contact Caroline Vermeulen, Sr specialist Talent Acquisition. Tel +31 (0)20 240 5246 or send us your details at firstname.lastname@example.org.
Acquisition will not be appreciated. Any unsolicited CV’s received by recruitment agencies will be treated as direct Kiadis applicants – without any fee obligations.
Kiadis Pharma is a clinical stage biopharmaceutical company developing innovative products to make bone marrow transplantations safer and more effective for patients. Kiadis Pharma believes that its innovative products have the potential to address the current risks and limitations connected with allogeneic hematopoietic stem cell transplantation (HSCT), thereby meeting a significant unmet medical need with its products.More about Kiadis Pharma